BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Goins B, Bao A, Phillips WT. Techniques for Loading Technetium-99m and Rhenium-186/188 Radionuclides into Preformed Liposomes for Diagnostic Imaging and Radionuclide Therapy. Methods Mol Biol 2017;1522:155-78. [PMID: 27837538 DOI: 10.1007/978-1-4939-6591-5_13] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Wang Z, Li J, Lin G, He Z, Wang Y. Metal complex-based liposomes: Applications and prospects in cancer diagnostics and therapeutics. J Control Release 2022;348:1066-88. [PMID: 35718211 DOI: 10.1016/j.jconrel.2022.06.012] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Woźniak M, Płoska A, Siekierzycka A, Dobrucki LW, Kalinowski L, Dobrucki IT. Molecular Imaging and Nanotechnology-Emerging Tools in Diagnostics and Therapy. Int J Mol Sci 2022;23:2658. [PMID: 35269797 DOI: 10.3390/ijms23052658] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Lu J, Li R, Mu B, Peng Y, Zhao Y, Shi Y, Guo L, Hai L, Wu Y. Multiple targeted doxorubicin-lonidamine liposomes modified with p-hydroxybenzoic acid and triphenylphosphonium to synergistically treat glioma. Eur J Med Chem 2021;230:114093. [PMID: 35007860 DOI: 10.1016/j.ejmech.2021.114093] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
4 Chang CH, Chang MC, Chang YJ, Chen LC, Lee TW, Ting G. Translating Research for the Radiotheranostics of Nanotargeted 188Re-Liposome. Int J Mol Sci 2021;22:3868. [PMID: 33918011 DOI: 10.3390/ijms22083868] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
5 Huang YS, Hsu WC, Lin CH, Lo SN, Cheng CN, Lin MS, Lee TW, Chang CH, Lan KL. Bi-Functional Radiotheranostics of 188Re-Liposome-Fcy-hEGF for Radio- and Chemo-Therapy of EGFR-Overexpressing Cancer Cells. Int J Mol Sci 2021;22:1902. [PMID: 33672989 DOI: 10.3390/ijms22041902] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
6 Shahzad K, Majid ASA, Khan M, Iqbal MA, Ali A. Recent advances in the synthesis of ( 99m Technetium) based radio-pharmaceuticals. Reviews in Inorganic Chemistry 2021;41:151-98. [DOI: 10.1515/revic-2020-0021] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
7 Peltek OO, Muslimov AR, Zyuzin MV, Timin AS. Current outlook on radionuclide delivery systems: from design consideration to translation into clinics. J Nanobiotechnology 2019;17:90. [PMID: 31434562 DOI: 10.1186/s12951-019-0524-9] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 10.3] [Reference Citation Analysis]
8 Kleynhans J, Grobler AF, Ebenhan T, Sathekge MM, Zeevaart J. Radiopharmaceutical enhancement by drug delivery systems: A review. Journal of Controlled Release 2018;287:177-93. [DOI: 10.1016/j.jconrel.2018.08.008] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
9 McKnight BN, Viola-Villegas NT. 89 Zr-ImmunoPET companion diagnostics and their impact in clinical drug development. J Labelled Comp Radiopharm 2018;61:727-38. [PMID: 29341222 DOI: 10.1002/jlcr.3605] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 5.4] [Reference Citation Analysis]
10 Zavaleta C, Ho D, Chung EJ. Theranostic Nanoparticles for Tracking and Monitoring Disease State. SLAS Technol 2018;23:281-93. [PMID: 29115174 DOI: 10.1177/2472630317738699] [Cited by in Crossref: 40] [Cited by in F6Publishing: 46] [Article Influence: 6.7] [Reference Citation Analysis]